USP7 Cooperates with NOTCH1 to Drive the Oncogenic Transcriptional Program in T-Cell LeukemiaPanagiotis Ntziachristos, Sofie Peirs, Niels Vandamme et al.|Clinical Cancer Research|2018Cited by 95
Functional Protein Network Activation Mapping Reveals New Potential Molecular Drug Targets for Poor Prognosis Pediatric BCP-ALLBenedetta Accordi, Giuseppe Basso|PLoS ONE|2010Cited by 48
Pre-clinical evaluation of second generation PIM inhibitors for the treatment of T-cell acute lymphoblastic leukemia and lymphomaRenate De Smedt, Pieter Van Vlierberghe, Sofie Peirs et al.|Haematologica|2018Cited by 32
SYK Targeting Represents a Potential Therapeutic Option for Relapsed Resistant Pediatric ETV6-RUNX1 B-Acute Lymphoblastic Leukemia PatientsValentina Serafin, Benedetta Accordi|International Journal of Molecular Sciences|2019Cited by 10
USP7 cooperates with NOTCH1 to drive the oncogenic transcriptional program in T cell leukemiaKelly M. Arcipowski, Panagiotis Ntziachristos, Carlos A. Martinez et al.|bioRxiv (Cold Spring Harbor Laboratory)|2018Cited by 5